RNXT
RenovoRx, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.42
−4.70%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 39.89x
- P/S forward
- 7.61x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 7.14x
- Price / sales
- 32.43x
- Price / cash flow
- -5.40x
Enterprise value
- Enterprise value
- $54.9M
- EV / sales
- 27.77x
- EV / EBITDA
- -4.47x
- EV / EBIT
- -4.09x
- Market cap
- $64.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026